See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
NFL
Baseball
Motorsports
Vatican
Social Media
South America
Catholic Church
Real Madrid
Tennis
Premier League
Soccer
Published • loading... • Updated

Pharmalittle: We're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, and more

Summary by STAT
Halozyme Therapeutics filed a lawsuit to block Merck from launching an easier-to-use version of its blockbuster cancer treatment Keytruda.

1 Articles

All
Left
Center
1
Right
STATSTAT
Center

Pharmalittle: We're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, and more

Halozyme Therapeutics filed a lawsuit to block Merck from launching an easier-to-use version of its blockbuster cancer treatment Keytruda.

·Boston, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States on Thursday, April 24, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Tariffs

Tariffs

Merck

Merck

Switzerland

Switzerland

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal